IL6 and myeloid sarcoma: In another study of 20 MS patients supplemented daily with fish oil containing EPA and DHA, despite a reduction in tumor necrosis factor (TNF)-α, IL-1b, IL-6, and NO over 1 year of treatment, no effects were noted on EDSS or relapse rate (Ramirez-Ramirez et al., 2013).